Advanced stage melanoma therapies: Detailing the present and exploring the future

Title
Advanced stage melanoma therapies: Detailing the present and exploring the future
Authors
Keywords
Metastatic melanoma, Immunotherapy, Targeted therapy, Combination therapy, CTLA-4, PD1, BRAF, Ipilimumab, Vemurafenib, Dabrafenib, Nivolumab, Pembrolizumab, MEDI4736, Talimogene, TVEC, Indoleamine 2,3-dioxygenase, Indoximod (D-1MT), Epacadostat
Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 133, Issue -, Pages 99-111
Publisher
Elsevier BV
Online
2018-11-16
DOI
10.1016/j.critrevonc.2018.11.002

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now